Form 4 for ELVN Enliven Therapeutics, Inc.
Accepted 2024-10-10 00:00:00 ET · period of report 2024-10-08 · accession 0001415889-24-024990 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-10 | 2024-10-08 | ELVN | Ballal Rahul D. | Dir | M - OptEx | $14.10 | +10.4K | 32.8K | +47% | +$146.9K |
| D | 2024-10-10 | 2024-10-08 | ELVN | Ballal Rahul D. | Dir | S - Sale+OE | $28.17 | -10.4K | 22.3K | -32% | -$293.5K |
| DM | 2024-10-10 | 2024-10-08 | ELVN | Ballal Rahul D. | Dir | M - OptEx | $0.00 | -10.4K | 12.3K | -46% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-08 | M | A | 6,314 | $19.68 | 28,655 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-08 | M | A | 4,106 | $5.52 | 32,761 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-08 | S | D | 10,420 | $28.17 | 22,341 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $28.00 to $28.48. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Derivative | Stock Option (right to buy) | 2024-10-08 | M | D | 6,314 | $0.00 | 69,428 | D | $19.68 · — to 2029-05-16 | 6,314 Common Stock | (F3) All of the shares subject to this option are fully vested and exercisable as of the date hereof. |
| 5 | Derivative | Stock Option (right to buy) | 2024-10-08 | M | D | 4,106 | $0.00 | 12,322 | D | $5.52 · — to 2032-01-28 | 4,106 Common Stock | (F4) The option, originally for 32,849 shares, vested as to one-fourth of the shares on January 28, 2023, and the remainder of the shares vest in 12 equal quarterly installments thereafter. |